01—Abstract
Summary
Summary of the 8-K filed March 31, 2025. Cited figures are marked; the original filing is the authoritative source.
Exelixis, Inc. filed this Form 8-K to report that on March 28, 2025, its Board of Directors, following a recommendation from the Compensation Committee, approved a Special Equity Award Program.
The program grants a one-time performance-based restricted stock unit (PSU) award to all employees of the Company and its subsidiaries, including named executive officers, under the 2017 Equity Incentive Plan. The Board states the program is intended to incentivize long-term performance aligned with shareholder value and to retain employees over a five-year transformational period. For named executive officers, the filing states that award values equal approximately two times the value of an annual long-term incentive award for similarly situated executives at peer companies placed at the 50th percentile.
The filing lists the number of PSU shares for Dr. Michael M. Morrissey (589,719), Mr. Christopher J. Senner (170,009), Dr. Dana T.
Aftab (132,819), Mr. Jeffrey J. Hessekiel (154,070) and Dr. Amy C. Peterson (159,383).
Vesting is tied to performance: the stock price must reach a volume-weighted average closing price of at least $60a per share over any consecutive 90-calendar-day period within the five-year performance period, and employees must generally remain employed through the fifth anniversary of the grant, subject to exceptions for qualifying terminations. If the price goal is not met within the performance period, the entire award is forfeited. The form of PSU agreement for employees at or above the vice president level is to be filed as an exhibit to the Form 10-Q for the period ending April 4, 2025.
02—Key points
Key Highlights
- Board approved a one-time performance-based RSU (PSU) award program for all Exelixis employees and subsidiaries on March 28, 2025.
- Program is granted under the Exelixis, Inc. 2017 Equity Incentive Plan, as amended and restated from time to time.
- Named executive officer awards are stated to be approximately two times the value of annual long-term incentive awards for similarly situated peer executives at the 50th percentile.
- Named executive officer PSU share counts: Morrissey 589,719; Senner 170,009; Aftab 132,819; Hessekiel 154,070; Peterson 159,383.
- Vesting requires a 90-consecutive-calendar-day volume-weighted average closing price of at least $60 per share during a five-year performance period, plus continued employment through the fifth anniversary, subject to exceptions.
- Entire award is forfeited if the stock price goal is not achieved within the performance period.
- Form of PSU agreement for vice president level and above will be filed as an exhibit to the Form 10-Q for the period ending April 4, 2025.
03—Questions
Frequently Asked Questions
What is the Special Equity Award Program?
It is a one-time program approved by the Board on March 28, 2025, providing performance-based restricted stock unit awards to all Exelixis employees and subsidiaries, including named executive officers, under the 2017 Equity Incentive Plan.
What stock price must be reached for the awards to vest?
The volume-weighted average closing price of Exelixis common stock must equal or exceed $60 per share for any consecutive 90-calendar-day period during the five-year performance period.
What happens if the stock price goal is not met?
If the price goal is not achieved within the performance period, the entire PSU award will be forfeited.
How many PSU shares were granted to the named executive officers?
Dr. Michael M. Morrissey received 589,719 shares, Mr. Christopher J. Senner 170,009, Dr. Dana T. Aftab 132,819, Mr. Jeffrey J. Hessekiel 154,070, and Dr. Amy C. Peterson 159,383.
Why did the Board adopt this program?
The Board believes the program will incentivize long-term performance directly aligned with shareholder value creation and retain employees over a five-year transformational period for the Company.
04—Continue